Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet therapy after lower extremity peripheral transluminal angioplasty
NL-OMON47750Phase 4Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in arteriosclerosis obliterans comparing Aspirin alone, Aspirin + clopidogrel and Ticagrelor (3 arms). Primary endpoint: Primary composite cardiovascular adverse events at 1 year. Started Feb 2020; status: active, not recruiting.
02
Drugs
aspirinclopidogrelticagrelor
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on NL-OMON47750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47750.